Makoto Furuta
Overview
Explore the profile of Makoto Furuta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaikumar S, Zhuang Z, Mannan P, Vortmeyer A, Furuta M, Dickerman R, et al.
Cell Cycle
. 2007 Mar;
6(7):836-42.
PMID: 17377495
Animal models of human diseases are widely used to address questions of tumor development. Selection of a particular animal model depends upon a variety of factors, among them: animal cost,...
2.
From tissue phenotype to proteotype: sensitive protein identification in microdissected tumor tissue
Zhuang Z, Huang S, Kowalak J, Shi Y, Lei J, Furuta M, et al.
Int J Oncol
. 2005 Dec;
28(1):103-10.
PMID: 16327985
Correlation of disease phenotype with protein profile (proteotype) is a significant challenge for biomedical research. The main obstacles have been the need to insure sufficient quantities of pure protein sample,...
3.
Pack S, Weil R, Vortmeyer A, Zeng W, Li J, Okamoto H, et al.
Cell Cycle
. 2005 Nov;
4(12):1758-60.
PMID: 16258289
Neurons, once committed, exit the cell cycle and undergo maturation that promote specialized activity and are believed to operate upon a stable genome. We used fluorescence in situ hybridization, selective...
4.
Vogel T, Vortmeyer A, Lubensky I, Lee Y, Furuta M, Ikejiri B, et al.
J Neurosurg
. 2005 Sep;
103(2):284-8.
PMID: 16175858
Object: Von Hippel-Lindau (VHL) disease is characterized by multiple tumors in specific organs. The cell of origin and the reason for the particular organ distribution of the tumors remains unknown....
5.
Vogel T, Zhuang Z, Li J, Okamoto H, Furuta M, Lee Y, et al.
Clin Cancer Res
. 2005 May;
11(10):3624-32.
PMID: 15897557
Introduction: Research into the pathogenesis, molecular signaling, and treatment of glioblastoma multiforme (GBM) has traditionally been conducted using cell lines derived from malignant gliomas. We compared protein expression patterns between...
6.
Suzuyama K, Shiraishi T, Oishi T, Ueda S, Okamoto H, Furuta M, et al.
Brain Res Mol Brain Res
. 2004 Oct;
129(1-2):44-53.
PMID: 15469881
Several proteins are known to be markedly expressed in the brain during cerebral ischemia, however the change in protein profiles within the cerebrospinal fluid (CSF) after an ischemic insult has...
7.
Furuta M, Shiraishi T, Okamoto H, Mineta T, Tabuchi K, Shiwa M
Brain Res Dev Brain Res
. 2004 Sep;
152(2):189-97.
PMID: 15351507
Neural stem cells (NSCs) are multipotential progenitor cells that have self-renewal activity. Since the fates of the NSCs in situ depend on their niche containing growth factors and cytokines, we...
8.
Furuta M, Weil R, Vortmeyer A, Huang S, Lei J, Huang T, et al.
Oncogene
. 2004 Aug;
23(40):6806-14.
PMID: 15286718
Glioblastoma multiforme (GBM) has been subdivided into two types based on clinical and genetic findings: primary tumors, which arise de novo, and secondary tumors, which progress from lower grade gliomas...
9.
Ueda S, Mineta T, Suzuyama K, Furuta M, Shiraishi T, Tabuchi K
Neuro Oncol
. 2003 Mar;
5(1):14-8.
PMID: 12626129
Glioblastomas rarely metastasize outside the CNS. We biologically characterized a case of secondary glioblastoma associated with extracranial progression and distant metastasis. A 42-year-old male patient was subjected to craniotomy for...